3-BROMO-IMIDAZO[1,5-A]PYRIMIDINE-8-CARBOXYLIC ACID ETHYL ESTER, 95.0%, 250mg

Columnas de cromatografía con frita, núcleo de vidrio esmerilado y conexión de extracción GL 18, 120 ml, 20 mm, 400 mm, 1 Pieza(s)

2-[3-(2-Dimethylamino-5-trifluoromethyl-pyridin-3-yl)-phenoxy]-propionic acid, 95.0%, 1g

1-[(4-isopropylphenyl)sulfonyl]piperazine, 100mg

4-(DIFLUOROMETHOXY)-5-FLUOROPYRIDIN-2-AMINE, 95%, 100mg

7-Bromo-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine, 95.0%, 1g

5-(chloromethyl)-3-methyl-1H-1,2,4-triazole hydrochloride, 95.0%, 250mg

Hyperoside, ROTICHROM® HPLC, 10 mg, envase de vidrio

N-CYCLOPROPYL-1-IMIDAZOLECARBOXAMIDE, 95.0%, 1g

Propyl 4-aminobenzoate, 95.0%, 500g

5-(2,4,6-Trifluorophenyl)oxazole, 98%, 500mg

4-(2-methylpyrimidin-4-yl)aniline, 1g

tert-butyl 2-aminoisonicotinate, 95.0%, 250mg